OKYO Pharma (OKYO) Shares Outstanding (2021 - 2026)
OKYO Pharma (OKYO) posted quarterly Shares Outstanding (Entity) of $52.5 million for Q1 2026, up 39.53% year-over-year from $37.6 million in Q1 2025, and up 39.53% quarter-over-quarter from $37.6 million in Q1 2025.
OKYO Pharma (OKYO) Shares Outstanding (2021 - 2026) Analysis & Trends
OKYO Pharma (OKYO) has reported Shares Outstanding (Entity) for 6 consecutive years, with $52.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 39.53% year-over-year to $52.5 million; the TTM figure through Mar 2026 stood at $52.5 million (up 39.53% YoY), while the FY2026 annual figure was $52.5 million, up 39.53% from the prior year.
- Shares Outstanding (Entity) improved to $52.5 million in Q1 2026 per OKYO's latest filing, from $37.6 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $52.5 million in Q1 2026 and bottomed at $15.1 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $32.9 million across 5 years, with a median of $33.8 million in 2024.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) soared 69.67% — and 2025, when it increased 11.15%.
- OKYO Pharma's Shares Outstanding (Entity) stood at $15.1 million in 2022, then jumped by 69.67% to $25.6 million in 2023, then surged by 32.41% to $33.8 million in 2024, then grew by 11.15% to $37.6 million in 2025, then soared by 39.53% to $52.5 million in 2026.
- Business Quant data shows OKYO's Shares Outstanding (Entity) at $52.5 million in Q1 2026, $37.6 million in Q1 2025, and $33.8 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | OKYO Pharma | 1.52 Bn | 1.52 Bn | - | 979.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.06 Mn |
| Sep 30, 2025 | 15.06 Mn |
| Mar 31, 2025 | 15.06 Mn |
| Sep 30, 2024 | 15.06 Mn |
| Mar 31, 2024 | 15.06 Mn |
| Sep 30, 2023 | 15.06 Mn |
| Mar 31, 2023 | 15.06 Mn |
| Mar 31, 2022 | 15.06 Mn |
| Mar 31, 2021 | 10.35 Mn |